Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Laguna Blends, Inc. (CSE: LAG) (LB6A.F) (OTC: LAGBF) Featured in The Canadian Securities Exchange Quarterly Magazine

Before the opening bell, Laguna Blends, Inc. (CSE: LAG) (FSE: LB6A.F) (OTC: LAGBF) announced its inclusion in the June 2016 Canadian Securities Exchange (CSE) quarterly magazine as one of four featured companies that are considered difference-makers in their respective industries. The company’s two-page profile gives prospective shareholders an overview of Laguna’s recent success in leveraging […]

Monaker Group (MKGI) Pursuing Market Driven Opportunities

Monaker Group (OTCQB: MKGI) is a technology driven travel agency that operates through its booking platform: NextTrip.com. The company is made up of a number of divisions and brands such as Maupintour, NextTrip, Voyage TV, and NextTrip Resorts. MKGI boasts more than 60 years of experience in the leisure and travel industries. Although the company […]

 

From Our Blog

Lixte Biotech Holdings Inc. (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships

April 9, 2026

Lixte Biotechnology (NASDAQ: LIXT) is emerging as a differentiated player in the oncology ecosystem, advancing a precision-driven approach to cancer treatment which focuses on improving the effectiveness of existing. As a clinical-stage pharmaceutical company, the company is advancing novel compounds built around a unique biological target, with its lead candidate, LB-100, at the nucleus of […]

Rotate your device 90° to view site.